Search Results 1-10 of 13535 for BPC-157

  1. Mayo Clinic offers unique regenerative medicine procedure for knee and hip joints hopes to expand to other injuries

    This Q&A with Daniel B. F. Saris, M.D., Ph.D., addresses the latest developments in an innovative regenerative medicine cartilage repair only offered at ...

  2. Treatment Of Patients With Recurrent High-Grade Glioma With APG-157 And Bevacizumab - Mayo Clinic

    The purpose of this study is to assess the toxicity and effectiveness of bevacizumab with APG-157 for recurrent high grade glioma patients with disease ...

  3. Sermorelin (injection route) - Side effects & dosage - Mayo Clinic

    Sermorelin is a synthetic (man-made) version of a naturally occurring substance that causes release of growth hormone from the pituitary gland. Growth hormone ...

  4. https://www.mayoclinic.org/chinese_condition_consolidated_concepts.xml

  5. https://www.mayoclinic.org/~/media/410DC08A1B274C6594A11A1F485AAACE

  6. Medical Research & Education - Mayo Clinic News Network

    157 · 158 · 159 … 362 · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery Science ...

  7. A Study Of CIN-107 In Adults With Primary Aldosteronism - Mayo Clinic

    The purpose of this study is to evaluate the change from baseline in systolic blood pressure (SBP) by automated office blood pressure monitoring (AOBPM), with ...

  8. A Study Of The Efficacy And Safety Of Upadacitinib (ABT-494) In Subjects With Moderately To Severely Active Crohn's Disease Who Have Inadequately Responded To Or Are Intolerant To Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and ...

  9. Medical Research & Education - Mayo Clinic News Network

    For years, cancer researchers have been trying to halt a type of molecule that's involved in several cancers. The molecules — enzymes known as trypsins[...] ...

  10. ECOSPOR III - SER-109 Versus Placebo In The Treatment Of Adults With Recurrent Clostridium Difficile Infection - Mayo Clinic

    The purpose of this study is to demonstrate the superiority of SER-109 vs placebo to reduce recurrence of CDI in adults up to 8 weeks after initiation of ...